DEC 17, 2019 9:00 AM PST

The role of SIRT1/LXR signaling in diabetic retinopathy

Speaker

Abstract
DATE:  December 17, 2019
TIME:   9:00am PST, 12:00pm EST
 
Purpose:
Liver x receptors (LXRs) are hypothesized to serve as a link between lipid metabolism and inflammation by promoting cholesterol efflux as well as exhibiting anti-inflammatory properties. NAD-dependent deacetylase SIRT1 is known to promote insulin secretion, reduce glucose tolerance and to play a critical role in regulating inflammation. SIRT1 has also been shown to interact with LXR to promote LXR activation. Additionally, previous literature has shown that starvation increases SIRT1 levels in mice. The purpose of this study was to investigate the role of SIRT1-LXR activation in control of inflammation and subsequent metabolic changes in retinal endothelial cells.
 
Methods:
Bovine retinal endothelial cells (BRECs) were treated with diabetic relevant stimulus TNFα (10ng/ml); LXR activator, DMHCA (1uM); or SIRT1 activator, SRT1720 (1uM). In order to model calorie restriction in vitro BRECs were serum starved (0% FBS) for 24hrs. SIRT1, IL1β, ABCA1 and ABCG1 were analyzed by qRT-PCR. Sirt1 activity was measured via histone deacetylase activity (HDAC) assay. LXR acetylation was measured via western blot analysis. Results: Treatment with pro-inflammatory cytokine, TNFα (10ng/ml) for 24hrs significantly increased cholesterol levels (p=0.0233, n=6), IL1β expression, IL6 expression and resulted in decreased levels of HDAC activity in BRECs. Activation of LXR or SIRT1 prevented TNFα-induced inflammation. Serum starvation resulted in a significant increase in HDAC activity (p=0.0005, n=6) and SIRT1 expression levels. Lastly, serum starvation caused a decrease in LXR acetylated levels in BRECs.
 
Conclusion:
The results of this study demonstrate that serum starvation promotes activation of the SIRT1-LXR pathway metabolism in retinal endothelial cells. Therefore, this study suggests that therapeutic fasting may serve to activate the SIRT1-LXR pathway providing the dual benefits of decreasing inflammation and promoting cholesterol metabolism in the retina.
 
Learning Objectives:
  • Understand the role of SIRT1-LXR activation in control of inflammation and subsequent metabolic changes in retinal endothelial cells.
  • Demonstrate how serum starvation promotes activation of the SIRT1-LXR pathway metabolism in retinal endothelial cells.
  • Explain how therapeutic fasting may serve to activate the SIRT1-LXR pathway providing the dual benefits of decreasing inflammation and promoting cholesterol metabolism in the retina.
 
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
DEC 17, 2019 9:00 AM PST

The role of SIRT1/LXR signaling in diabetic retinopathy


Specialty

Molecular Biology

Cell Biology

Immunology

Biotechnology

Cancer Research

Genetics

Laboratory Testing

Molecular Diagnostics

Biochemistry

Clinical Diagnostics

Microbiology

Biomarkers

Clinical Research

Genomics

Cell Culture

Geography

North America61%

Asia17%

Europe17%

South America3%

Africa3%

Registration Source

Email Promotions43%

Website Visitors40%

WAVE Newsletter Promotion4%

Social Media Promotions1%

Client/Sponsor Promotions1%

Other10%

Job Title

Educator/Faculty16%

Medical Laboratory Technician16%

Research Scientist15%

Student9%

Clinical Laboratory Scientist8%

Executive7%

Lab Management6%

Medical Doctor/Specialist5%

Facility/Department Manager5%

Scientist4%

Marketing/Sales2%

Chemist2%

Post Doc2%

Genetic Counselor1%

Biologist1%

Consultant1%

Organization

Academic Institution29%

Hospital16%

Clinical Laboratory12%

Biotech Company5%

Medical Center5%

Research Institute4%

Consultant3%

Life Science Company3%

Diagnostic Company2%

Government2%

Medical School2%

Non-Profit Organization2%

Pharmaceutical Company1%

Industrial Company1%

Other2%


Show Resources
Show Resources
Connect with us